Enable Injections Competitors and Similar CompaniesClear all
Enable Injections's competitors and similar companies include AccuRna, SkinJect and Entos Pharmaceuticals.
 Enable Injections Enable Injections is a company developing and manufacturing on-body subcutaneous drug delivery systems. |  AccuRna AccuRna (株式会社アキュルナ) is a company developing a drug delivery system (DDS) for nucleic acid therapeutics, both of short chain including ASO, siRNA, miRNA and long chain, mRNA as a therapeutic drug.
|  SkinJect Skinject is developing a drug delivery system for the treatment of non-melanoma skin cancers. |  Entos Pharmaceuticals Entos Pharmaceuticals is a company that develops nucleic acid-based therapies using its proprietary Fusogenix drug delivery system. | |
Founding Date | Founding Date 2010 | Founding Date 2015 | Founding Date 2015 | Founding Date 2016 |
Type | Type Private | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations Cincinnati, US HQ | Locations Bunkyo City, JP HQ Kawasaki, JP | Locations Pittsburgh, US HQ | Locations Edmonton, CA HQ |
Employees | Employees 1932% increase | Employees 6 | Employees 2 | Employees 44 |
Funding | ||||
Latest funding round | Latest funding round $ 150m (over 4 years ago) | Latest funding round $ 1.8m (over 8 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 215m | Total funding raised $ 6.5m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
AccuRna
HQ
Bunkyo City, JP
Employees
6
AccuRna (株式会社アキュルナ) is a company developing a drug delivery system (DDS) for nucleic acid therapeutics, both of short chain including ASO, siRNA, miRNA and long chain, mRNA as a therapeutic drug.
View companySkinJect
HQ
Pittsburgh, US
Employees
2
Skinject is developing a drug delivery system for the treatment of non-melanoma skin cancers.
View companyEntos Pharmaceuticals
HQ
Edmonton, CA
Employees
44
Entos Pharmaceuticals is a company that develops nucleic acid-based therapies using its proprietary Fusogenix drug delivery system.
View company